Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-1”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Testing effectiveness (Phase 2)Study completedNCT00827112
What this trial is testing

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

Who this might be right for
Human Immunodeficiency Virus-1
ViiV Healthcare 129
Testing effectiveness (Phase 2)Study completedNCT02485509
What this trial is testing

Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection

Who this might be right for
HIV Infection
Viriom 28
Early research (Phase 1)Study completedNCT00000972
What this trial is testing

A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 64
Testing effectiveness (Phase 2)Study completedNCT03784079
What this trial is testing

A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults

Who this might be right for
HIV Infections
ViiV Healthcare 34
Testing effectiveness (Phase 2)Ended earlyNCT04900038
What this trial is testing

A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults

Who this might be right for
HIV Infections
ViiV Healthcare 85
Large-scale testing (Phase 3)Study completedNCT02733419
What this trial is testing

Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection

Who this might be right for
HIV Infections
Hoffmann-La Roche 84
Testing effectiveness (Phase 2)Study completedNCT03601806
What this trial is testing

Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection

Who this might be right for
Human Immunodeficiency Virus 1 PositiveSkin Kaposi Sarcoma
AIDS Malignancy Consortium 26
Testing effectiveness (Phase 2)Study completedNCT01384734
What this trial is testing

HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 254
Early research (Phase 1)WithdrawnNCT05700734
What this trial is testing

MK-8510 Monotherapy for the Treatment of Anti-retroviral naïve Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8510-002)

Who this might be right for
HIV-1Human Immunodeficiency Virus 1Immunodeficiency Virus Type 1, Human+1 more
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT01641809
What this trial is testing

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 244
Early research (Phase 1)WithdrawnNCT05769569
What this trial is testing

Safety and Efficacy of Neutralizing Antibodies and Vaccination for Induction of HIV Remission

Who this might be right for
HIV-1-infection
Henry M. Jackson Foundation for the Advancement of Military Medicine
Not applicableUnknownNCT01467024
What this trial is testing

Evaluation of the MP Diagnostics HTLV Blot 2.4

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 600
Not applicableUnknownNCT01541631
What this trial is testing

Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes

Who this might be right for
AnemiaIntestinal HelminthiasisIntestinal Schistosomiasis+3 more
Catholic University of Health and Allied Sciences 2,000
Large-scale testing (Phase 3)Study completedNCT03682848
What this trial is testing

Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents

Who this might be right for
HIV Infections
ViiV Healthcare 32
Early research (Phase 1)Study completedNCT00000958
What this trial is testing

A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 8
Early research (Phase 1)UnknownNCT05328583
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral HRS5685 in Healthy Subjects

Who this might be right for
Human Immunodeficiency Virus-1 (HIV-1) Infection
RetroLead (Shanghai) BioPharma Co., Ltd. 64
Testing effectiveness (Phase 2)Study completedNCT02527096
What this trial is testing

A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 110
Large-scale testing (Phase 3)Study completedNCT02831673
What this trial is testing

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 719
Very early researchStudy completedNCT02655471
What this trial is testing

Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection

Who this might be right for
HTLV-I InfectionsTropical Spastic Paraparesis
Universidad Peruana Cayetano Heredia 10
Load More Results